We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

197 hedge funds and large institutions have $1.16B invested in Heron Therapeutics in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

137% more call options, than puts

Call options by funds: $3.56M | Put options by funds: $1.51M

64% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 45

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

4.46% more ownership

Funds ownership: 102% → 106.46% (+4.5%)

4% more funds holding

Funds holding: 189 → 197 (+8)

28% less capital invested

Capital invested by funds: $1.61B → $1.16B (-$450M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
197
Holders Change
+8
Holders Change %
+4.23%
% of All Funds
3.45%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
23
Increased
74
Reduced
45
Closed
14
Calls
$3.56M
Puts
$1.51M
Net Calls
+$2.06M
Net Calls Change
-$405K

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$26.9M
2
State Street
State Street
Massachusetts
+$21.7M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$16.5M
4
Goldman Sachs
Goldman Sachs
New York
+$11.1M
5
SI
Sofinnova Investments
California
+$10.1M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$21.9M
2
Invesco
Invesco
Georgia
-$20.1M
3
Franklin Resources
Franklin Resources
California
-$15.7M
4
CS
Candriam SCA
Luxembourg
-$7.2M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$6.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$7M +$3.35M +275,195 +72%
Fidelity Investments
27
Fidelity Investments
Massachusetts
$6.85M +$117K +9,627 +2%
Deutsche Bank
28
Deutsche Bank
Germany
$5.66M +$105K +8,655 +2%
NAM
29
Nexpoint Asset Management
Texas
$5.34M – – –
PAM
30
Panagora Asset Management
Massachusetts
$5.3M -$1.62K -133 -0%
Balyasny Asset Management
31
Balyasny Asset Management
Illinois
$5.14M +$1.09M +89,339 +23%
KBC Group
32
KBC Group
Belgium
$4.83M +$5.5M +452,150 New
PHS
33
Pekin Hardy Strauss
Illinois
$4.74M -$4.06M -333,315 -43%
IHAM
34
Integral Health Asset Management
New York
$4.38M +$3.77M +310,000 +310%
HWAM
35
Hennion & Walsh Asset Management
New Jersey
$3.92M -$160K -13,125 -3%
Morgan Stanley
36
Morgan Stanley
New York
$3.9M -$1.89M -155,629 -30%
OCM
37
Orchard Capital Management
Illinois
$3.84M – – –
Bank of New York Mellon
38
Bank of New York Mellon
New York
$3.55M +$393K +32,251 +11%
American Century Companies
39
American Century Companies
Missouri
$3.52M +$1.35K +111 +0%
SEI Investments
40
SEI Investments
Pennsylvania
$3.48M -$305K -25,061 -7%
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
$3.39M -$3.79M -311,146 -50%
Rafferty Asset Management
42
Rafferty Asset Management
New York
$2.86M +$1.19M +98,085 +58%
Squarepoint
43
Squarepoint
New York
$2.68M +$477K +39,142 +18%
VOYA Investment Management
44
VOYA Investment Management
Georgia
$2.65M -$153K -12,552 -5%
UBS Group
45
UBS Group
Switzerland
$2.65M +$2.92M +239,993 +2,957%
ORI
46
Oak Ridge Investments
Illinois
$2.55M -$74.1K -6,086 -2%
Swiss National Bank
47
Swiss National Bank
Switzerland
$2.28M +$271K +22,300 +12%
Citigroup
48
Citigroup
New York
$2.1M -$1.23M -100,996 -34%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$2.06M +$437K +35,909 +23%
PPA
50
Parametric Portfolio Associates
Washington
$1.9M +$212K +17,440 +11%
1
2
3 4 5

HRTX Hedge Fund Activity: Q3 2021 in Review

197 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2021, worth a combined $1.16B — down 28% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new HRTX positions and 14 closed out — a net gain of 9 holders — while 74 added to existing stakes and 45 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $26.9M. The largest seller was Wellington Management Group, cutting an estimated $21.9M.

  • 197 institutional investors held Heron Therapeutics (HRTX) as of Q3 2021, up from 189 in Q2 2021.
  • Funds reported $1.16B of Heron Therapeutics stock for Q3 2021, down 28% quarter-over-quarter.
  • 23 funds opened new Heron Therapeutics positions in Q3 2021 and 14 closed out, a net change of +9 holders.
  • The largest Heron Therapeutics buyer in Q3 2021 was UBS O'Connor, an estimated $26.9M added.
  • The largest Heron Therapeutics seller in Q3 2021 was Wellington Management Group, an estimated $21.9M sold.

Based on aggregated 13F filings for Q3 2021.